According to the specific oxidation position, the 12/15-LOX is in charge of catalyzing AA to 12-/15- hydroperoxyeicosatetraenoic acid (12-/15-HpETE) (Ackermann et al., 2017)
The protein sample (250 g protein /30 L) was mixed with 270 L of UA (100 mM TrisHCl (pH 8.5) containing 8 M Urea) in the filter unit, and centrifuged at 14,000 g for 15 min
These results show that although the expected therapeutic effect has not been achieved, AVV-based therapy has acceptable safety
The administration usually takes place in a clinical setting, where a healthcare professional administers the treatment via an IV drip
"The appeal is real, because it skips digestion and acts fast, which is exactly why it has earned its place in the wellness world," she says
Specific risks include asymmetry, changes in nipple sensation (usually temporary), poor scarring, and potential need for revision surgery